ALFA Filings
Every announcement, straight from the exchange
Every Parmax Pharma management change announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Parmax Pharma Ltd announced the resignation of Mr. Nikhil Uchat as an Independent Director of the Company, effective October 08, 2026.
Parmax Pharma Limited announced the appointment of Dhiren Shah and Sunil Shah as Directors. Additionally, Ms. Salma Thobhani resigned as a Non-Executive Non-Independent Director.
Parmax Pharma Ltd has approved the re-appointment of Dr. Umang Gosalia (DIN: 05153830) as Managing Director for a five-year term starting June 28, 2026. Dr. Gosalia, associated with the firm since 2016, oversees production activities. The appointment is subject to shareholder approval at the upcoming general meeting.